Eagle Rock Investment Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
6,800
0.04% 142
2026
Q1
$328K Hold
6,800
0.05% 136
2025
Q4
$330K Hold
6,800
0.05% 141
2025
Q3
$321K Hold
6,800
0.05% 139
2025
Q2
$329K Hold
6,800
0.05% 132
2025
Q1
$377K Hold
6,800
0.06% 124
2024
Q4
$328K Hold
6,800
0.05% 127
2024
Q3
$392K Hold
6,800
0.07% 123
2024
Q2
$330K Hold
6,800
0.06% 121
2024
Q1
$330K Hold
6,800
0.06% 119
2023
Q4
$338K Hold
6,800
0.07% 114
2023
Q3
$365K Hold
6,800
0.08% 106
2023
Q2
$360K Hold
6,800
0.08% 108
2023
Q1
$370K Sell
6,800
-4,000
-37% -$195K 0.09% 106
2022
Q4
$526K Hold
10,800
0.12% 105
2022
Q3
$411K Hold
10,800
0.11% 101
2022
Q2
$540K Hold
10,800
0.13% 94
2022
Q1
$554K Sell
10,800
-100
-0.9% -$5.16K 0.12% 88
2021
Q4
$546K Buy
+10,900
New +$539K 0.1% 79

Other funds holding SNY

Eagle Rock Investment Company's SNY Position: Q2 2026 in Review

Eagle Rock Investment Company held its Sanofi (SNY) position steady in Q2 2026 at 6,800 shares worth $290K. The position accounts for 0.04% of the portfolio, ranked #142.

Eagle Rock Investment Company first reported a position in SNY in Q4 2021 and has held it in 19 quarters since. The position peaked at $554K in Q1 2022. 277 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Eagle Rock Investment Company held 6,800 shares of Sanofi worth $290K as of Q2 2026.
  • Eagle Rock Investment Company left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up 0.04% of Eagle Rock Investment Company's portfolio in Q2 2026, its #142 holding.
  • Eagle Rock Investment Company first reported a position in Sanofi in Q4 2021 and has held it in 19 quarters since.
  • Eagle Rock Investment Company's Sanofi position peaked at $554K in Q1 2022.
  • 277 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.